Drugs / ASP4901
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02038868 | Jul 2013 → Apr 2014 | benign prostatic hyperplasia | Astellas Pharma Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP4901 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02038868 ↗ |
| Route | Oral | “oral dose of ASP4901 once daily for 4 weeks” NCT02038868 ↗ |